Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00051220 · ClinicalTrials.gov registry record · Phase 1
Treatment for Specific Phobias in Children
A Phase 1 study of Anxiety Disorders and Phobic Disorders, sponsored by Virginia Polytechnic Institute and State University.
- Completed
- Registry status
- Phase 1
- Development phase
- 150
- Enrollment target
- 2
- Study locations
NCT00051220: Completed Phase 1 study of Anxiety Disorders and Phobic Disorders, sponsored by Virginia Polytechnic Institute and State University.
NCT00051220 is a Phase 1 study of Anxiety Disorders and Phobic Disorders that has completed, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 150 participants, below the 1,138-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (87% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00051220, a Phase 1 study of Anxiety Disorders and Phobic Disorders, has completed, sponsored by Virginia Polytechnic Institute and State University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 150 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will compare the effectiveness of three treatments in reducing symptoms of phobia in children and adolescents.
Conditions Studied
Interventions
- BEHAVIORAL One-Session Treatment for Specific Phobias
Study Locations (2)
Virginia
- VA Polytech. Institute and State University - Blacksburg
Other
- University of Stockholm - Stockholm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2001-10 |
| Est. Completion | 2006-09 |
| Phase | Phase 1 |
What the finished NCT00051220 record still lists
NCT00051220 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,138-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (87% lower).
The record links to 2 conditions, with Anxiety Disorders appearing as the primary indexed condition, and to 1 intervention - of which One-Session Treatment for Specific Phobias is the first listed.
NCT00051220 reports a single indexed study location in Virginia, Other.
Frequently Asked Questions
What is clinical trial NCT00051220 about?
NCT00051220 is a clinical study titled "Treatment for Specific Phobias in Children". This study will compare the effectiveness of three treatments in reducing symptoms of phobia in children and adolescents.
What is the current status of trial NCT00051220?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 150 participants. The study started on 2001-10. Estimated completion is 2006-09.
What conditions does trial NCT00051220 study?
This clinical trial studies the following conditions: Anxiety Disorders, Phobic Disorders.
What interventions are being tested in trial NCT00051220?
The interventions under investigation include: One-Session Treatment for Specific Phobias (BEHAVIORAL).
Who is sponsoring clinical trial NCT00051220?
This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00051220 being conducted?
This trial has 2 study locations across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00051220's enrollment target sits among peer trials
150 31st of 84 higher than 51 of 84 other Anxiety Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anxiety Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Antiglucocorticoid Therapy for Cognitive Impairment in Late-life Anxiety Disorders
COMPLETED · Phase 1
-
Mindfulness-based Stress Reduction and Cognitive Function in Stress and Aging
COMPLETED · Phase 1
-
Integrated CBT for Cannabis Dependence With Co-occurring Anxiety Disorders
COMPLETED · Phase 1
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
-
CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos
RECRUITING · NA
-
Trial With the Treatment of Sertraline in Youth With Generalized, Separation and/or Social Anxiety Disorders.
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia